Ranolazine is associated with cardiovascular and metabolic improvement: a win-win for patients with diabetes
- PMID: 16267073
- DOI: 10.1093/eurheartj/ehi624
Ranolazine is associated with cardiovascular and metabolic improvement: a win-win for patients with diabetes
Comment on
-
Effects of ranolazine on exercise tolerance and HbA1c in patients with chronic angina and diabetes.Eur Heart J. 2006 Jan;27(1):42-8. doi: 10.1093/eurheartj/ehi495. Epub 2005 Sep 21. Eur Heart J. 2006. PMID: 16176940 Clinical Trial.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
Miscellaneous
